🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Maximum Lysis on Thromboelastography as a Marker of Systemic Severity in Acute Allergic Reactions

Recruitingn/aAges 12 Years - anyAllMayo Clinic
NCT07905911 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this research is to better understand the mechanisms behind allergic reactions.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 12 years or older. * Presentation to the emergency department with suspected allergic reaction, anaphylaxis, or angioedema based on chief concern. * Ability to obtain thromboelastography during the acute presentation. Exclusion Criteria: * Known inherited coagulation or fibrinolytic disorders. * Active major bleeding at presentation. * Receipt of thrombolytic therapy. * Inability to obtain thromboelastography promptly.
💊

What it tests

  • Thromboelastogram
📍

Where

1 site
Mayo Clinic
Rochester, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy